Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TrendingWallStreet.com Announces Data Research on CTIX, AER, PTRC, and IVAN

AER, PTRC

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.

Cellceutix Corporation (OTC: CTIX) shares closed up a modest 0.54 percent on Monday with nearly 500,000 shares traded. The stock was one of the most actively traded stocks in the OTC market. The company, a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, announced that it has submitted the application to the Institutional Review Board responsible for the Company's planned Phase 2b clinical trial of its novel antibiotic Brilacidin as a drug candidate for Acute Bacterial Skin and Skin Structure Infections.

Get more information on Cellceutix Corporation and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/CTIX

AerCap Holdings N.V. (NYSE: AER) shares closed up 33.05 percent on Monday with nearly 11 million shares traded. The stock hit a new 52-week high of $34.67 during intra-day trading and was one of the biggest gainers in the NYSE. AerCap is buying AIG's aircraft leasing arm, called International Lease Finance Corp., for $3 billion in cash and 97.56 million shares of new AerCap stock. At today's stock price, the deal is worth about $6.2 billion and will make AIG the largest shareholder with 46% of AerCap's stock.

Get more information on AerCap Holdings N.V. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/AER

Petro River Oil Corp (OTCBB: PTRC) shares closed up 33.33 percent on Monday with a little over 7 million shares traded. The stock was one of the biggest gainers in the OTCBB market. The company announced that on December 12, 2013, it closed a private placement of common stock at $0.08 per share for total gross proceeds of $6.5 million. In addition the Company issued a warrant to purchase additional common stock at a strike price of $0.1356 prior to December 12, 2015.

Get more information on Petro River Oil Corp and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/PTRC

Ivanhoe Energy Inc. (NASDAQ: IVAN) shares closed down 15.48 percent on Monday and hit a new 52-week low of $0.35 during intra-day trading. The stock traded about 1.6 million shares. The company announced that it has learned that the Alberta Energy Regulator (AER) intends to develop a new long-term policy for reviewing shallow steam assisted gravity drainage (SAGD) applications in Alberta. Following discussions with each affected industry applicant, and by the end of January 2014, the AER plans to publish interim guidelines. Then, following extensive industry and stakeholder engagement, the AER will develop a long-term policy. This decision and process affects all shallow SAGD projects, not just Ivanhoe's Tamarack project.

Get more information on Ivanhoe Energy Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/IVAN

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today